Blog
Watch: 2022 Translational Medicine Awardees Explain Their Research
For the Translational Science 2023 meeting, the PhRMA Foundation’s 2022 Translational Medicine award recipients recorded videos showcasing their research ...
Q&A with Dr. Yongbin Liu: Working to Overcome Drug-Resistant Cancers
Dr. Yongbin Liu, a postdoctoral fellow at Houston Methodist Research Institute, is working to develop safer, more potent drugs that ...
Q&A with Dr. Norah Crossnohere: Studying Patient Preferences on Multi-Cancer Early Detection Tests
2023 PhRMA Foundation awardee Norah Crossnohere, PhD, is working to measure patient preferences on multi-cancer early detection tests ...
PhRMA Foundation Welcomes Robert Plenge to the Board of Directors
The PhRMA Foundation today announced the appointment to its Board of Directors of Robert Plenge, MD, PhD, Executive Vice President, ...
PhRMA Foundation Predoctoral Awardee Publishes Cancer Research in Nature
Albert S. Agustinus, a 2021 PhRMA Foundation awardee, published in Nature about his research exploring an unexpected connection between two ...
Q&A with Cydney Martell: Optimizing the Design of Protein Therapeutics
Proteins are large molecules in the body that perform many vital functions, and many diseases are related to malfunctioning proteins ...
Q&A with Helen Omuya: Improving Life for Older Veterans Through Deprescribing Interventions
The number of medications prescribed to older adults for various health complaints can sometimes accumulate to daunting levels over time ...
Q&A with FDA Chief Scientist and PhRMA Foundation Alumna Dr. Namandjé Bumpus
Dr. Namandjé N. Bumpus is approaching her one-year anniversary as Chief Scientist at the Food and Drug Administration (FDA). But ...
From Health Policy Expert to Patient: The Perils of Navigating Insurance
This is the second in a series of blog posts by PhRMA Foundation President Dr. Amy M. Miller on health ...
